“Comparative efficacy of spironolactone, eplerenone, nebivolol and moxonidine in patients with resistant arterial hypertension”, UJC, vol. 25, no. 6, pp. 65–71, Jan. 2019, doi: 10.31928/1608-635X-2018.6.6571.